Orange Book product · Brand (NDA)
FERRIPROX
DEFERIPRONE
At a glance
Apr 20, 2018
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 20, 2018
8 yr 3 mo ago
Today
Exclusivity ends · ODE-417
Orphan-drug exclusivity (7 years)
Apr 30, 2028
in 1 yr 11 mo
Exclusivity ends · ODE-418
Orphan-drug exclusivity (7 years)
Apr 30, 2028
in 1 yr 11 mo
Exclusivity ends · ODE-419
Orphan-drug exclusivity (7 years)
Apr 30, 2028
in 1 yr 11 mo
Patent 8703156 expires
Listed drug product patent expiration.
Oct 26, 2029
in 3 yr 5 mo
Pharmaceutical detail
Active ingredient
DEFERIPRONE
Strength
80MG/ML
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
NDA 208030
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Marketing exclusivity (3)
- ODE-417Orphan-drug exclusivity (7 years)
Apr 30, 2028
in 1 yr 11 mo
- ODE-418Orphan-drug exclusivity (7 years)
Apr 30, 2028
in 1 yr 11 mo
- ODE-419Orphan-drug exclusivity (7 years)
Apr 30, 2028
in 1 yr 11 mo
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8703156 | Oct 26, 2029 | in 3 yr 5 mo | ProductU-3083 |
